Assessment of uterus position as a surrogate for high-risk clinical target volume with respect to the applicator position for multiple fractions of brachytherapy in cervical cancer

Cooper, Rachel; Brearley, Elizabeth; HÜRMÜZ, PERVİN; Musunuru, Hima; Richardson, Carolyn; Swift, Sara; Orton, Jane; Bownes, Peter

doi:10.1007/s00404-014-3350-1

Assessment of uterus position as a surrogate for high-risk clinical target volume with respect to the applicator position for multiple fractions of brachytherapy in cervical cancer

Copy For Citation

Cooper R., Brearley E., HÜRMÜZ P., Musunuru H. B., Richardson C., Swift S., ...More

ARCHIVES OF GYNECOLOGY AND OBSTETRICS, vol.290, no.6, pp.1201-1205, 2014 (SCI-Expanded)

Publication Type: Article / Article
Volume: 290 Issue: 6
Publication Date: 2014
Doi Number: 10.1007/s00404-014-3350-1
Journal Name: ARCHIVES OF GYNECOLOGY AND OBSTETRICS
Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Page Numbers: pp.1201-1205
Keywords: High-dose-rate brachytherapy, Cervical cancer, Applicator (IU) position, HDR, RECOMMENDATIONS, RADIOTHERAPY, UTERINE, TERMS
Hacettepe University Affiliated: Yes

Abstract

Hybrid magnetic resonance imaging/computerized tomography (MRI/CT) planning for high-dose-rate (HDR) brachytherapy in cervical cancer with MR/CT fusion for the first fraction followed by CT for fraction 2 and 3 is used at our center. The aim of this study is to evaluate the position of applicator intrauterine tube (IU) in relation to uterine serosa with each fraction of intracavitary high-dose-rate brachytherapy.